Drug development companies

Celon Pharma, an integrated pharmaceutical company, researches, manufactures, and sells drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders.

ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer.

Bridge Biotherapeutics is a company that specializes in the research and development of drugs.

Zim is a pharmaceutical product manufacturing company.

Pharmanutra, a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices.

Frontage Holdings is a holding company that operates in the pharmaceutical market.

Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.

Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.

Tibet Yiming Xiya Pharmaceutical Technology (西藏一鸣喜亚药业科技) is a company that produces and sells pharmaceutical products.

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.

Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.